Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Upstream Bio (UPB) Net Margin (2023 - 2025)

Upstream Bio (UPB) has 2 years of Net Margin data on record, last reported at 4941.14% in Q3 2025.

  • For Q3 2025, Net Margin fell 147607.0% year-over-year to 4941.14%; the TTM value through Sep 2025 reached 4386.35%, down 191218.0%, while the annual FY2024 figure was 3223.42%, 161606.0% down from the prior year.
  • Net Margin reached 4941.14% in Q3 2025 per UPB's latest filing, down from 4265.31% in the prior quarter.
  • Across five years, Net Margin topped out at 2189.06% in Q1 2024 and bottomed at 4941.14% in Q3 2025.